Courses

Lung Cancer

Target audience

Post-graduate physicians will be provided with adequate information in thoracic oncology to manage lung cancer patients
Practicing chest physicians will benefit from the knowledge update on the management of lung cancer provided by this training

Educational aims
To provide participants with:

Basic full training covering a wide range of topics in thoracic oncology
Comprehensive information allowing full initiation to the management of lung cancer
Up to date information for chest physicians and oncologists in charge of patients with lung cancer

Chemoprevention of Lung Cancer N. Van Zandwijk (Amsterdam, The Netherlands)
Tumours of the lung, larynx and pleura P. Boffetta (Lyon, France)
Tobacco K. Zarogoulidis (Thessaloniki, Greece)
Professional risks and environmental factors P. Boffetta (Lyon, France)
Screening R. M. Huber (Munich, Germany)
TNM clinical classification of lung carcinoma E. Brambilla (Grenoble, France)
Preneoplastic lesions A. Nicholson (London, United Kingdom)
Lung cancer biology E. Brambilla (Grenoble, France)
Clinical presentation of lung cancer S. G. Spiro (London, United Kingdom)
Staging: locoregional H-B. Ris (Lausanne, Switzerland)
Staging, distant metastases B. Bergman (Gothenburg, Sweden)
Diagnosis and staging of lung cancer: PET-scan M. Lonneux (Brussels, Belgium)
Endoscopic Treatment R. M. Huber (Munich, Germany)
Surgery for non-small cell lung cancer P. E. van Schil (Edegem, Belgium)
Neo(adjuvant) therapies combined with surgery in loco(regional) NSCLC A. Depierre (Besançon, France)
New potentials of radiotherapy and chemotherapy for lung cancer P. Van Houtte (Brussels, Belgium)
Systemic chemotherapy J-P. Sculier (Brussels, Belgium)
New drugs in lung cancer K. Zarogoulidis (Thessaloniki, Greece)
Survival prognostic factors for NSCLC T. Berghmans (Bruxelles, Belgium)
Chemotherapy vs best supportive care S. G. Spiro (London, United Kingdom)
Limited disease P. Van Houtte (Brussels, Belgium)
Extensive disease J-P. Sculier (Brussels, Belgium)
Brain metastases in small-cell lung cancer: prevention and treatment T. Berghmans (Bruxelles, Belgium)
Prognostic factors B. Bergman (Gothenburg, Sweden)